PICO Portalanswers from OpenAlex & ORCID
Amanda N. Fader
ResearcherPublications, citations & collaboration network
Amanda N. Fader is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Amanda N. Fader have?
PICO Portalindexed works
Amanda N. Fader has 378 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Amanda N. Fader have?
PICO Portalcitation count
Amanda N. Fader has 22,629 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Amanda N. Fader?
PICO Portalh-index
Amanda N. Fader has an h-index of 67 in OpenAlex.
What is the i10-index of Amanda N. Fader?
PICO Portali10-index
Amanda N. Fader has an i10-index of 174 in OpenAlex.
What is the ORCID of Amanda N. Fader?
PICO Portalorcid
The ORCID for Amanda N. Fader is on the source record.
What is the OpenAlex record for Amanda N. Fader?
PICO Portalopenalex
The OpenAlex for Amanda N. Fader is on the source record.
What are the most-cited papers on Amanda N. Fader?
PICO Portalmost cited works
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon Luber, Fay Wong, Nilofer S. Azad, Agnieszka A. Rucki, Dan Laheru, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Tim F. Greten, Austin G. Duffy, Kristen K. Ciombor, Aleksandra Eyring, Bao H. Lam, Andrew K. Joe, Soonmo Peter Kang, Matthias Holdhoff, Ludmila Danilova, Leslie Cope, Christian F. Meyer, Shibin Zhou, Richard M. Goldberg, Deborah K. Armstrong, Katherine M. Bever, Amanda N. Fader, Janis M. Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, James R. Eshleman, Bert Vogelstein, Robert A. Anders, Luis A. Díaz
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, Angeles Alvarez Secord, Laura J. Havrilesky, David M. O’Malley, Floor Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William J. Lowery, Karim ElSahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan‐Arin Silasi, Peter E. Schwartz, Alessandro D. Santin
Uterine Neoplasms, Version 1.2014
Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu‐Rustum, Sachin M. Apte, Susana M. Campos, John K. Chan, Kathleen R. Cho, David E. Cohn, Marta A. Crispens, Nefertiti C. duPont, Patricia J. Eifel, Amanda N. Fader, Christine M. Fisher, David K. Gaffney, Suzanne George, Ernest Han, Warner K. Huh, John R. Lurain, Lainie P. Martin, David G. Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small, Nelson N.H. Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian, Miranda Hughes